• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, July 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Mechanism of tumor metastasis and tumor-suppressive role of UDP-glucose revealed

Bioengineer by Bioengineer
June 26, 2019
in Cancer
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: DICP and SIBCB

Scientists from Dalian Institute of Chemical Physics (DICP) and Shanghai Institute of Biochemistry and Cell Biology (SIBCB) of the Chinese Academy of Sciences revealed that UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Their findings were published in Nature.

Metastasis is the primary cause of cancer morbidity and mortality, and accounts for up to 95% of cancer-related deaths. UDP-glucose 6-dehydrogenase (UGDH) is a key enzyme in the uronic acid pathway that converts UDP-glucose to UDP-glucuronic acid; Hu antigen R (HuR) is a ubiquitously expressed RNA-binding protein that binds to the 3′-untranslated region (UTR) region of many short-lived mRNAs and increases their stability.

Dr. YANG Weiwei’s group from SIBCB has performed the experimental research. The results show that, upon EGFR activation, phosphorylated UGDH interacts with HuR and converts UDP-glucose to UDP-glucuronic acid. The resulting UDP-glucoronic acid attenuated the UDP-glucose-mediated inhibition of the association of HuR with SNAI1 mRNA, thus enhancing SNAI1 mRNA stability.

Increased SNAIL expression initiates the epithelial-mesenchymal transition, thereby promoting tumor cell migration and lung cancer metastasis. These findings reveal a tumor-suppressive role for UDP-glucose in lung cancer metastasis and uncover the mechanism by which UGDH promotes tumor metastasis by increasing SNAI1 mRNA stability.

Dr. Li Guohui’s group from DICP has performed molecular dynamics (MD) simulations to elucidate the structural basis underlying the UDP-Glc- or UDP-GlcUA-regulated binding of HuR to mRNA. The MD results showed that both UDP-Glc and UDP-GlcUA bound to the same RNA-binding domain of HuR.

The binding affinity of UDP-Glc with HuR is stronger than UDP-GlcUA with HuR, which is consistent with experimental results. Essentially, two mutants of HuR(Y63F) and HuR(N134A) were generated and studied. It was found that HuR(N134A) had a much lower affinity for both metabolites than HuR(WT) and HuR(Y63F), but still bound to SNAI1 mRNA, and tumor cells rescued with rHuR(N134A) showed more migration.

###

This research was supported by the State Key Laboratory of Molecular Reaction Dynamics, the Strategic Priority Research Program of the Chinese Academy of Sciences and the National Natural Science Foundation of China.

Media Contact
WANG Yongjin
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s41586-019-1340-y

Tags: cancerCell BiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

UCSF Study Finds Rapid Rise in Breast Cancer Among Asian American Women

July 10, 2026

Radiation Therapy Clinic Closures May Widen US Cancer Care Disparities

July 10, 2026

New Nanotechnology Switch Halts Cancer Growth and Boosts Immune Attack

July 10, 2026

Advances and Challenges in Targeting BET Proteins in Solid Tumors

July 10, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Ultra-fine bubbles revolutionize future of inkjet printing technology

Polyunsaturated Fatty Acid Synthesis Influences Ferroptosis Sensitivity with Low Arachidonic Acid

Real-Time Pain and Activity Patterns in Older Adults with Chronic Pain

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 84 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.